Skip to main content
. 2023 Sep 29;29(23):4949–4957. doi: 10.1158/1078-0432.CCR-23-1397

Table 1.

Patient and tumor characteristics of all stage I p53abn ECs previously classified as low-grade (grade 1–2) endometrioid.

Total
N = 55 (100%)
Age
 Mean (range) 67 (45–86)
Stage
 IA 32 (58.2%)
 IB 23 (41.8%)
LVSI
 Absent 46 (92.0%)
 Present 4 (8.0%)
Adjuvant treatment
 No adjuvant treatment 28 (50.9%)
 EBRT 12 (21.8%)
 VBT 13 (23.6%)
 CT (+ EBRT) 2 (3.6%)

Abbreviation: CT, chemotherapy.